These Stocks Are in Spotlight on M&A-Related News
With the stock market losing ground on the back of expectations of a possible interest rate hike by the Fed next month, fueled by strong non-farm payroll and unemployment data.
Mylan Inc. (Old Filings) (MYL)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
Five Foreign Stocks To Buy Now
In order to diversify portfolios and reduce exposure to one particular country, it is generally a good idea for retail investors to buy shares of companies which generate a major chunk of their revenues...
Billionaires Can't Live Without These 10 Stocks
At Insider Monkey, we track more than 700 elite hedge funds and use their combined wisdom to identify 15 exceptional small-cap stocks every quarter, which our backtesting and ongoing results show as having...
Billionaires See A Healthy Future For These Healthcare Stocks
The S&P 500 Health Care Index has advanced by 21.11% over the past three-year period, which is significantly higher than the S&P 500’s return of 10.30% over the same time span.
David Tepper's Thoughts On The Market And The Major Tech Stock He Got Rid Of
David Tepper of Appaloosa Management, who has the distinction of having Carnegie Mellon's business school being named after him, is without a doubt an accomplished and respected investor, one that we...
Teva Ascends On Allergan Generics Purchase, Mylan NV (MYL) Withdrawal
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares reached as high as $83 per share in pre-market trading Monday, or over 18% higher than the stock’s closing price on Friday, as the firm announced...
Looking At Newly Owned Activist Stocks
This article is temporarily removed from Insider Monkey.
Weight Watchers (WTW)' Horrid Q1 Not Enough to Stop North Tide Capital From Double Digit Returns
Conan Laughlin’s North Tide Capital posted impressive first quarter returns of 10.1% from its 14 long positions in companies valued at $1 billion or greater.
Charter Oak Partners Management Loves These Stocks
Charter Oak Partners Management is a fundamentally driven Long/Short hedge fund that focuses mainly on equity investments. It was founded by Jerrold N.
Investing in Counteracting Biological and Chemical Agents
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological agents.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
